A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

By embedding standardised questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

The BRCA 14 nano-chip test, which is common in Israel, targets women of Ashkenazi and Ethiopian descent who have not been ...

MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...

Abstract: The efficient management of electric vehicle (EV) charging infrastructure is critical to meeting the growing demand for sustainable transportation. This study addresses the Electric Vehicle ...

Scientists have identified mutations in the CPD gene as a key cause of a rare congenital hearing loss, revealing how ...

A new study by investigators at Dana-Farber Cancer Institute and Harvard Medical School is providing one of the most detailed ...

Researchers confirmed that sperm accumulate mutations over the years, increasing the risk of transmitting diseases to ...